- All sections
- C - Chemistrymetallurgy
- C07D - Heterocyclic compounds
- C07D 295/14 - Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
Patent holdings for IPC class C07D 295/14
Total number of patents in this class: 163
10-year publication summary
12
|
4
|
4
|
4
|
4
|
4
|
10
|
8
|
6
|
0
|
2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
Principal owners for this class
Owner |
All patents
|
This class
|
---|---|---|
Alnylam Pharmaceuticals, Inc. | 1153 |
17 |
Daiichi Sankyo Company, Limited | 1859 |
8 |
Takeda Pharmaceutical Company Limited | 2707 |
7 |
Astellas Pharma Inc. | 1088 |
6 |
Abbvie Inc. | 1803 |
5 |
Toyama Chemical Co., Ltd. | 102 |
5 |
Boehringer Ingelheim International GmbH | 4705 |
3 |
Pfizer Inc. | 3371 |
3 |
Abbott Laboratories | 2411 |
3 |
Taisho Pharmaceutical Co., Ltd. | 869 |
3 |
SK on Co., Ltd. | 1580 |
3 |
Janssen Pharmaceutica N.V. | 3407 |
2 |
Actavis Group PTC ehf | 471 |
2 |
Arena Pharmaceuticals, Inc. | 366 |
2 |
Bioprojet | 44 |
2 |
Dainippon Sumitomo Pharma Co., Ltd. | 195 |
2 |
Dongjin Semichem Co., Ltd. | 481 |
2 |
Galderma Research & Development | 405 |
2 |
Gifu University | 133 |
2 |
Kyoto Pharmaceutical Industries, Ltd. | 19 |
2 |
Other owners | 82 |